Related Experiment Video
Updated: Jun 23, 2026
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
The simultaneous use of nanovesicles and magnetic nanoparticles for cancer targeting and imaging
Sara Salatin1,2, Maryam Azarfarin3, Afsaneh Farjami4
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Cancer is increasingly being recognized as a global health issue with considerable unmet medical need. Despite the rapid progression of anticancer pharmaceuticals, there are still significant challenges for the effective management of cancer. In many circumstances, cancer cells are difficult to detect and treat. Combination of nanovesicles (NVs) and magnetic nanoparticles (MNPs), referred as magnetic nanovesicles (MNVs), is now well recognized as a potential theranostic option for improving cancer treatment outcomes and reducing adverse effects. MNVs can be used for monitoring the long-term fate and functional benefits of cancer therapy. Moreover, MNV-mediated hyperthermia mechanism has been explored as a potential technique for triggering cancer cell death, and/or controlled release of laden cargo. In this review, we focus on the unique characteristics of MNVs as a promising avenue for targeted drug delivery, diagnosis, and treatments of cancer or tumor. Moreover, we discuss critical considerations related to the issues raised in this area, which will guide future research toward better anti-cancer therapeutics for clinical applications.
Insights
Magnetic nanovesicles (MNVs) offer a promising theranostic approach for cancer. This review highlights MNVs for targeted drug delivery, diagnosis, and treatment, guiding future anti-cancer therapeutics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Cancer presents a significant global health challenge with unmet medical needs.
- Current anticancer treatments face challenges in effective cancer cell detection and management.
- Magnetic nanovesicles (MNVs), combining nanovesicles and magnetic nanoparticles, emerge as a promising theranostic strategy.
Purpose of the Study:
- To review the unique characteristics of magnetic nanovesicles (MNVs) for cancer theranostics.
- To explore the potential of MNVs in targeted drug delivery, cancer diagnosis, and treatment.
- To identify critical considerations for advancing MNV research in clinical applications.
Main Methods:
- Review of current literature on magnetic nanovesicles (MNVs) in cancer research.
- Analysis of MNV properties for targeted drug delivery and diagnostic applications.
- Evaluation of MNV-mediated hyperthermia and controlled cargo release mechanisms.
Main Results:
- MNVs show potential for improved cancer treatment outcomes and reduced adverse effects.
- MNVs can be utilized for monitoring long-term therapeutic effects.
- MNV-mediated hyperthermia offers a method for cancer cell death induction and drug delivery.
Conclusions:
- Magnetic nanovesicles (MNVs) represent a significant advancement in cancer theranostics.
- Further research into MNVs is crucial for developing next-generation anti-cancer therapeutics.
- MNVs hold promise for targeted drug delivery, enhanced diagnostics, and effective cancer treatment strategies.
